☒
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
|
90-0199783
|
(State or other jurisdiction of incorporation or organization)
|
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
1275 Market Street
|
San Francisco
|
California
|
94103-1410
|
(Address of principal executive offices)
|
|
|
(Zip Code)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Class A common stock, $0.001 par value
|
DLB
|
The New York Stock Exchange
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
Item 2.
|
||
|
|
|
Item 3.
|
||
|
|
|
Item 4.
|
||
|
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
Item 1A.
|
||
|
|
|
Item 2.
|
||
|
|
|
Item 6.
|
||
|
|
|
|
Abbreviation
|
|
Term
|
AAC
|
|
Advanced Audio Coding
|
AFS
|
|
Available-For-Sale (Securities)
|
AOCI
|
|
Accumulated Other Comprehensive Income
|
APIC
|
|
Additional-Paid In-Capital
|
ASC
|
|
Accounting Standards Codification
|
ASP
|
|
Average Selling Price
|
ASU
|
|
Accounting Standards Update
|
ATSC
|
|
Advanced Television Systems Committee
|
AVC
|
|
Advanced Video Coding
|
AVR
|
|
Audio/Video Receiver
|
CE
|
|
Consumer Electronics
|
CES
|
|
Consumer Electronics Show
|
CODM
|
|
Chief Operating Decision Maker
|
COGS
|
|
Cost Of Goods Sold
|
COSO
|
|
Committee Of Sponsoring Organizations (Of The Treadway Commission)
|
DD
|
|
Dolby Digital®
|
DD+
|
|
Dolby Digital Plus™
|
DMA
|
|
Digital Media Adapter
|
DTV
|
|
Digital Television
|
DVB
|
|
Digital Video Broadcasting
|
DVD
|
|
Digital Versatile Disc
|
EPS
|
|
Earnings Per Share
|
ESP
|
|
Estimated Selling Price
|
ESPP
|
|
Employee Stock Purchase Plan
|
FASB
|
|
Financial Accounting Standards Board
|
FCPA
|
|
Foreign Corrupt Practices Act
|
G&A
|
|
General & Administrative
|
HD
|
|
High Definition
|
HDR
|
|
High-Dynamic Range
|
HDTV
|
|
High Definition Television
|
HE-AAC
|
|
High Efficiency Advanced Audio Coding
|
HEVC
|
|
High Efficiency Video Coding
|
HFR
|
|
High Frame Rate
|
HTIB
|
|
Home Theater In-A-Box
|
IC
|
|
Integrated Circuit
|
IBR
|
|
Incremental Borrowing Rate
|
IP
|
|
Intellectual Property
|
IPO
|
|
Initial Public Offering
|
IPTV
|
|
Internet Protocol Television
|
IT
|
|
Information Technology
|
LP
|
|
Limited Partner/Partnership
|
ME
|
|
Multiple Element
|
NOL
|
|
Net Operating Loss
|
OCI
|
|
Other Comprehensive Income
|
ODD
|
|
Optical Disc Drive
|
OECD
|
|
Organization For Economic Co-Operation & Development
|
OEM
|
|
Original Equipment Manufacturer
|
OTT
|
|
Over-The-Top
|
PC
|
|
Personal Computer
|
PCS
|
|
Post-Contract Support
|
PP&E
|
|
Property, Plant, & Equipment
|
PSO
|
|
Performance-Based Stock Option
|
PSU
|
|
Performance-Based Restricted Stock Unit
|
R&D
|
|
Research & Development
|
ROU
|
|
Right-Of-Use
|
RSU
|
|
Restricted Stock Unit
|
S&M
|
|
Sales & Marketing
|
SERP
|
|
Supplemental Executive Retirement Plan
|
SoC
|
|
System(s)-On-A-Chip
|
SSP
|
|
Standalone Selling Price
|
STB
|
|
Set-Top Box
|
TPE
|
|
Third Party Evidence
|
TSR
|
|
Total Stockholder Return
|
UHD
|
|
Ultra High Definition
|
U.S. GAAP
|
|
Generally Accepted Accounting Principles In The United States
|
|
December 27,
2019 |
September 27,
2019 |
||||
ASSETS
|
|
|
||||
Current assets:
|
|
|
||||
Cash and cash equivalents
|
$
|
741,429
|
|
$
|
797,210
|
|
Restricted cash
|
11,726
|
|
8,383
|
|
||
Short-term investments
|
170,234
|
|
119,146
|
|
||
Accounts receivable, net of allowance for doubtful accounts of $8,898 and $9,775
|
191,001
|
|
189,115
|
|
||
Contract assets
|
204,963
|
|
195,651
|
|
||
Inventories, net
|
29,104
|
|
32,331
|
|
||
Prepaid expenses and other current assets
|
52,551
|
|
39,704
|
|
||
Total current assets
|
1,401,008
|
|
1,381,540
|
|
||
Long-term investments
|
141,720
|
|
179,587
|
|
||
Property, plant, and equipment, net
|
549,495
|
|
537,432
|
|
||
Operating lease right-of-use assets
|
71,071
|
|
—
|
|
||
Intangible assets, net
|
175,981
|
|
180,891
|
|
||
Goodwill
|
335,443
|
|
334,829
|
|
||
Deferred taxes
|
123,284
|
|
114,075
|
|
||
Other non-current assets
|
95,282
|
|
93,395
|
|
||
Total assets
|
$
|
2,893,284
|
|
$
|
2,821,749
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
||||
Current liabilities:
|
|
|
||||
Accounts payable
|
$
|
13,700
|
|
$
|
15,212
|
|
Accrued liabilities
|
242,052
|
|
268,144
|
|
||
Income taxes payable
|
2,318
|
|
3,506
|
|
||
Contract liabilities
|
19,785
|
|
19,991
|
|
||
Operating lease liabilities
|
15,604
|
|
—
|
|
||
Total current liabilities
|
293,459
|
|
306,853
|
|
||
Non-current contract liabilities
|
23,917
|
|
24,404
|
|
||
Non-current operating lease liabilities
|
57,985
|
|
—
|
|
||
Other non-current liabilities
|
179,222
|
|
177,462
|
|
||
Total liabilities
|
554,583
|
|
508,719
|
|
||
|
|
|
||||
Stockholders’ equity:
|
|
|
||||
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 64,649,011 shares issued and outstanding at December 27, 2019 and 63,911,270 at September 27, 2019
|
58
|
|
58
|
|
||
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,229,820 shares issued and outstanding at December 27, 2019 and 36,229,820 at September 27, 2019
|
41
|
|
41
|
|
||
Retained earnings
|
2,351,251
|
|
2,327,877
|
|
||
Accumulated other comprehensive (loss)
|
(18,060
|
)
|
(20,625
|
)
|
||
Total stockholders’ equity – Dolby Laboratories, Inc.
|
2,333,290
|
|
2,307,351
|
|
||
Controlling interest
|
5,411
|
|
5,679
|
|
||
Total stockholders’ equity
|
2,338,701
|
|
2,313,030
|
|
||
Total liabilities and stockholders’ equity
|
$
|
2,893,284
|
|
$
|
2,821,749
|
|
|
Fiscal Quarter Ended
|
|||||
|
December 27,
2019 |
December 28,
2018 |
||||
Revenue:
|
|
|
||||
Licensing
|
$
|
257,683
|
|
$
|
260,279
|
|
Products and services
|
34,194
|
|
42,097
|
|
||
Total revenue
|
291,877
|
|
302,376
|
|
||
|
|
|
||||
Cost of revenue:
|
|
|
||||
Cost of licensing
|
12,342
|
|
11,397
|
|
||
Cost of products and services
|
24,973
|
|
27,232
|
|
||
Total cost of revenue
|
37,315
|
|
38,629
|
|
||
|
|
|
||||
Gross margin
|
254,562
|
|
263,747
|
|
||
|
|
|
||||
Operating expenses:
|
|
|
||||
Research and development
|
57,650
|
|
58,647
|
|
||
Sales and marketing
|
95,118
|
|
85,602
|
|
||
General and administrative
|
52,529
|
|
50,813
|
|
||
Restructuring charges
|
675
|
|
14
|
|
||
Total operating expenses
|
205,972
|
|
195,076
|
|
||
|
|
|
||||
Operating income
|
48,590
|
|
68,671
|
|
||
|
|
|
||||
Other income/expense:
|
|
|
||||
Interest income
|
4,932
|
|
5,185
|
|
||
Interest expense
|
(72
|
)
|
(45
|
)
|
||
Other income, net
|
1,004
|
|
443
|
|
||
Total other income
|
5,864
|
|
5,583
|
|
||
|
|
|
||||
Income before income taxes
|
54,454
|
|
74,254
|
|
||
(Provision for)/benefit from income taxes
|
(5,863
|
)
|
24,104
|
|
||
Net income including controlling interest
|
48,591
|
|
98,358
|
|
||
Less: net loss/(income) attributable to controlling interest
|
162
|
|
(139
|
)
|
||
Net income attributable to Dolby Laboratories, Inc.
|
$
|
48,753
|
|
$
|
98,219
|
|
|
|
|
||||
Net income per share:
|
|
|
||||
Basic
|
$
|
0.49
|
|
$
|
0.96
|
|
Diluted
|
$
|
0.47
|
|
$
|
0.93
|
|
Weighted-average shares outstanding:
|
|
|
||||
Basic
|
100,336
|
|
102,677
|
|
||
Diluted
|
103,078
|
|
106,130
|
|
||
|
|
|
||||
Related party rent expense:
|
|
|
||||
Included in operating expenses
|
$
|
70
|
|
$
|
880
|
|
Included in net income attributable to controlling interest
|
$
|
(106
|
)
|
$
|
176
|
|
|
|
|
||||
Cash dividend declared per common share
|
$
|
0.22
|
|
$
|
0.19
|
|
Cash dividend paid per common share
|
$
|
0.22
|
|
$
|
0.19
|
|
|
Fiscal Quarter Ended
|
|||||
|
December 27,
2019 |
December 28,
2018 |
||||
Net income including controlling interest
|
$
|
48,591
|
|
$
|
98,358
|
|
Other comprehensive income:
|
|
|
||||
Currency translation adjustments, net of tax of $40 and $0
|
3,620
|
|
(3,728
|
)
|
||
Unrealized gain/(loss) on investments, net of tax of ($261) and $40
|
(1,162
|
)
|
770
|
|
||
Unrealized gain on cash flow hedges, net of tax of ($37) and $0
|
284
|
|
—
|
|
||
Total other comprehensive income/(loss), net of tax
|
2,742
|
|
(2,958
|
)
|
||
|
|
|
||||
Total comprehensive income
|
51,333
|
|
95,400
|
|
||
Less: comprehensive (income) attributable to controlling interest
|
(15
|
)
|
12
|
|
||
Comprehensive income attributable to Dolby Laboratories, Inc.
|
$
|
51,318
|
|
$
|
95,412
|
|
|
Dolby Laboratories, Inc.
|
|
|
||||||||||||||||||
|
Common
Stock
|
Additional
Paid-In Capital |
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income/(Loss)
|
Total Dolby
Laboratories,
Inc.
|
Controlling
Interest
|
Total
|
||||||||||||||
Balance at September 27, 2019
|
$
|
99
|
|
$
|
—
|
|
$
|
2,327,877
|
|
$
|
(20,625
|
)
|
$
|
2,307,351
|
|
$
|
5,679
|
|
$
|
2,313,030
|
|
Net income
|
—
|
|
—
|
|
48,753
|
|
—
|
|
48,753
|
|
(162
|
)
|
48,591
|
|
|||||||
Other comprehensive income, net of tax
|
—
|
|
—
|
|
—
|
|
2,565
|
|
2,565
|
|
177
|
|
2,742
|
|
|||||||
Distributions to controlling interest
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(283
|
)
|
(283
|
)
|
|||||||
Stock-based compensation expense
|
—
|
|
22,614
|
|
—
|
|
—
|
|
22,614
|
|
—
|
|
22,614
|
|
|||||||
Repurchase of common stock
|
—
|
|
(26,705
|
)
|
(3,298
|
)
|
—
|
|
(30,003
|
)
|
—
|
|
(30,003
|
)
|
|||||||
Cash dividends declared and paid on common stock
|
—
|
|
—
|
|
(22,081
|
)
|
—
|
|
(22,081
|
)
|
—
|
|
(22,081
|
)
|
|||||||
Common stock issued under employee stock plans
|
—
|
|
24,373
|
|
—
|
|
—
|
|
24,373
|
|
—
|
|
24,373
|
|
|||||||
Tax withholdings on vesting of restricted stock
|
—
|
|
(20,282
|
)
|
—
|
|
—
|
|
(20,282
|
)
|
—
|
|
(20,282
|
)
|
|||||||
Balance at December 27, 2019
|
$
|
99
|
|
$
|
—
|
|
$
|
2,351,251
|
|
$
|
(18,060
|
)
|
$
|
2,333,290
|
|
$
|
5,411
|
|
$
|
2,338,701
|
|
|
|
|
|
|
|
|
|
|
Dolby Laboratories, Inc.
|
|
|
||||||||||||||||||
|
Common
Stock
|
Additional
Paid-In Capital |
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income/(Loss)
|
Total Dolby
Laboratories,
Inc.
|
Controlling
Interest
|
Total
|
||||||||||||||
Balance at September 28, 2018
|
$
|
102
|
|
$
|
66,127
|
|
$
|
2,313,539
|
|
$
|
(15,832
|
)
|
$
|
2,363,936
|
|
$
|
6,567
|
|
$
|
2,370,503
|
|
Net income
|
—
|
|
—
|
|
98,219
|
|
—
|
|
98,219
|
|
139
|
|
98,358
|
|
|||||||
Other comprehensive loss, net of tax
|
—
|
|
—
|
|
—
|
|
(2,807
|
)
|
(2,807
|
)
|
(151
|
)
|
(2,958
|
)
|
|||||||
Distributions to controlling interest
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(906
|
)
|
(906
|
)
|
|||||||
Stock-based compensation expense
|
—
|
|
21,482
|
|
—
|
|
—
|
|
21,482
|
|
—
|
|
21,482
|
|
|||||||
Repurchase of common stock
|
—
|
|
(82,203
|
)
|
(30,342
|
)
|
—
|
|
(112,545
|
)
|
—
|
|
(112,545
|
)
|
|||||||
Cash dividends declared and paid on common stock
|
—
|
|
—
|
|
(19,573
|
)
|
—
|
|
(19,573
|
)
|
—
|
|
(19,573
|
)
|
|||||||
Common stock issued under employee stock plans
|
—
|
|
14,272
|
|
—
|
|
—
|
|
14,272
|
|
—
|
|
14,272
|
|
|||||||
Tax withholdings on vesting of restricted stock
|
(1
|
)
|
(19,678
|
)
|
—
|
|
—
|
|
(19,679
|
)
|
—
|
|
(19,679
|
)
|
|||||||
Balance at December 28, 2018
|
$
|
101
|
|
$
|
—
|
|
$
|
2,361,843
|
|
$
|
(18,639
|
)
|
$
|
2,343,305
|
|
$
|
5,649
|
|
$
|
2,348,954
|
|
|
|
|
|
|
|
|
|
|
Fiscal Quarter-To-Date Ended
|
|||||
|
December 27,
2019 |
December 28,
2018 |
||||
Operating activities:
|
|
|
||||
Net income including controlling interest
|
$
|
48,591
|
|
$
|
98,358
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
||||
Depreciation and amortization
|
20,239
|
|
20,029
|
|
||
Stock-based compensation
|
22,614
|
|
21,482
|
|
||
Amortization of premium on investments
|
160
|
|
309
|
|
||
Provision for doubtful accounts
|
575
|
|
1,605
|
|
||
Deferred income taxes
|
(9,174
|
)
|
(32,571
|
)
|
||
Restructuring charge for exit of leased facility
|
486
|
|
—
|
|
||
Other non-cash items affecting net income
|
(10
|
)
|
3,393
|
|
||
Changes in operating assets and liabilities:
|
|
|
||||
Accounts receivable, net
|
(2,331
|
)
|
17,736
|
|
||
Contract assets
|
(9,310
|
)
|
(33,519
|
)
|
||
Inventories
|
767
|
|
(2,709
|
)
|
||
Operating lease right-of-use assets
|
(8,644
|
)
|
—
|
|
||
Prepaid expenses and other assets
|
(13,245
|
)
|
(13,157
|
)
|
||
Accounts payable and accrued liabilities
|
(30,785
|
)
|
(26,332
|
)
|
||
Income taxes, net
|
945
|
|
1,546
|
|
||
Contract liabilities
|
(724
|
)
|
(678
|
)
|
||
Operating lease liabilities
|
8,664
|
|
—
|
|
||
Other non-current liabilities
|
2,341
|
|
1,460
|
|
||
Net cash provided by operating activities
|
31,159
|
|
56,952
|
|
||
|
|
|
||||
Investing activities:
|
|
|
||||
Purchases of investment securities
|
(129,325
|
)
|
(63,329
|
)
|
||
Proceeds from sales of investment securities
|
97,717
|
|
32,582
|
|
||
Proceeds from maturities of investment securities
|
17,876
|
|
19,785
|
|
||
Purchases of property, plant, and equipment
|
(23,385
|
)
|
(18,539
|
)
|
||
Purchase of intangible assets
|
(290
|
)
|
(12,065
|
)
|
||
Net cash used in investing activities
|
(37,407
|
)
|
(41,566
|
)
|
||
|
|
|
||||
Financing activities:
|
|
|
||||
Proceeds from issuance of common stock
|
24,373
|
|
14,272
|
|
||
Repurchase of common stock
|
(30,003
|
)
|
(112,545
|
)
|
||
Payment of cash dividend
|
(22,081
|
)
|
(19,573
|
)
|
||
Distribution to controlling interest
|
(283
|
)
|
(906
|
)
|
||
Shares repurchased for tax withholdings on vesting of restricted stock
|
(20,282
|
)
|
(19,679
|
)
|
||
Net cash used in financing activities
|
(48,276
|
)
|
(138,431
|
)
|
||
|
|
|
||||
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash
|
2,086
|
|
(2,419
|
)
|
||
Net decrease in cash, cash equivalents, and restricted cash
|
(52,438
|
)
|
(125,464
|
)
|
||
Cash, cash equivalents, and restricted cash at beginning of period
|
805,593
|
|
925,250
|
|
||
Cash, cash equivalents, and restricted cash at end of period
|
$
|
753,155
|
|
$
|
799,786
|
|
|
|
|
||||
Supplemental disclosure:
|
|
|
||||
Cash paid for income taxes, net of refunds received
|
$
|
17,999
|
|
$
|
10,722
|
|
|
|
|
||||
Non-cash investing activities:
|
|
|
||||
Property, plant, and equipment purchased and unpaid at period-end
|
$
|
(582
|
)
|
$
|
6,642
|
|
Purchase consideration payable for intangibles
|
$
|
2,610
|
|
$
|
—
|
|
A.
|
Identification of the Contract or Contracts with Customers
|
B.
|
Identification of Performance Obligations in a Contract
|
•
|
Licensing. We license our technologies, including patents, to a range of customers who incorporate them into their products for enhanced audio, imaging and voice functionality across broadcast, mobile, CE, PC, gaming, and other markets.
|
•
|
Product Sales. We design and provide audio and imaging products for the cinema, television, broadcast, communications, and entertainment industries.
|
•
|
Services. We provide various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment, including equipment training, mixing room alignment, equalization, as well as audio, color and light image calibration.
|
•
|
PCS. We provide PCS for products sold and for the equipment leased, and we support the implementation of our licensing technologies in our licensees’ products.
|
•
|
Equipment Leases. We collaborate with established cinema exhibitors to offer Dolby Cinema, a branded premium cinema offering for movie audiences by leasing equipment and licensing our intellectual property. We also lease hardware that facilitates the Dolby conferencing experience, including the Dolby Conference Phone, and the Dolby Voice Room solution.
|
•
|
Licensing Administration Fees. We generate service fees for managing patent pools on behalf of third party patent owners through our wholly-owned subsidiary, Via Licensing Corporation.
|
•
|
Digital cinema server hardware and embedded software, which is highly dependent on and highly interrelated with the hardware. Accordingly, the hardware and embedded software represent a single performance obligation.
|
•
|
The right to support and maintenance, which is included with the purchase of the digital cinema server hardware, is a distinct performance obligation.
|
•
|
The right to receive commissioning services is a distinct performance obligation within the sale of the Dolby Atmos Cinema Processor. These services consist of the review of venue designs specifying proposed speaker placement as well as calibration services performed for installed speakers to ensure optimal playback.
|
C.
|
Determination of Transaction Price for Performance Obligations in a Contract
|
D.
|
Allocation of Transaction Price to Distinct Performance Obligations in a Contract
|
E.
|
Revenue Recognition as Control is Transferred to a Customer
|
F.
|
Disaggregation of revenue
|
|
Fiscal Quarter Ended
|
||||||||||
Revenue By Geographic Location
|
December 27, 2019
|
|
December 28, 2018
|
||||||||
United States
|
$
|
107,627
|
|
37
|
%
|
|
$
|
119,799
|
|
40
|
%
|
International
|
184,250
|
|
63
|
%
|
|
182,577
|
|
60
|
%
|
||
Total revenue
|
$
|
291,877
|
|
100
|
%
|
|
$
|
302,376
|
|
100
|
%
|
G.
|
Contract assets and liabilities
|
|
December 27, 2019
|
September 27, 2019
|
Change ($)
|
Change (%)
|
|||||||
Accounts receivable, net
|
$
|
191,001
|
|
$
|
189,115
|
|
$
|
1,886
|
|
1
|
%
|
Contract assets
|
204,963
|
|
195,651
|
|
9,312
|
|
5
|
%
|
|||
Contract liabilities - current
|
19,785
|
|
19,991
|
|
(206
|
)
|
(1
|
)%
|
|||
Contract liabilities - non-current
|
23,917
|
|
24,404
|
|
(487
|
)
|
(2
|
)%
|
|
December 27,
2019 |
|
September 27,
2019 |
||||
Trade accounts receivable
|
$
|
148,625
|
|
|
$
|
151,996
|
|
Accounts receivable from patent administration program licensees
|
51,274
|
|
|
46,894
|
|
||
Accounts receivable, gross
|
199,899
|
|
|
198,890
|
|
||
Less: allowance for doubtful accounts
|
(8,898
|
)
|
|
(9,775
|
)
|
||
Total
|
$
|
191,001
|
|
|
$
|
189,115
|
|
|
December 27,
2019 |
|
September 27,
2019 |
||||
Raw materials
|
$
|
6,933
|
|
|
$
|
8,031
|
|
Work in process
|
4,432
|
|
|
4,872
|
|
||
Finished goods
|
17,739
|
|
|
19,428
|
|
||
Total
|
$
|
29,104
|
|
|
$
|
32,331
|
|
|
December 27,
2019 |
|
September 27,
2019 |
||||
Prepaid expenses
|
$
|
28,774
|
|
|
$
|
17,997
|
|
Other current assets
|
23,105
|
|
|
20,924
|
|
||
Income tax receivable
|
672
|
|
|
783
|
|
||
Total
|
$
|
52,551
|
|
|
$
|
39,704
|
|
|
December 27,
2019 |
|
September 27,
2019 |
||||
Accrued royalties
|
$
|
3,107
|
|
|
$
|
2,957
|
|
Amounts payable to patent administration program partners
|
58,015
|
|
|
58,899
|
|
||
Accrued compensation and benefits
|
60,698
|
|
|
78,716
|
|
||
Accrued professional fees
|
16,165
|
|
|
19,216
|
|
||
Unpaid PP&E additions
|
14,350
|
|
|
15,332
|
|
||
Accrued customer refunds
|
18,222
|
|
|
24,299
|
|
||
Other accrued liabilities
|
71,495
|
|
|
68,725
|
|
||
Total
|
$
|
242,052
|
|
|
$
|
268,144
|
|
|
December 27,
2019 |
|
September 27,
2019 |
||||
Supplemental retirement plan obligations
|
$
|
3,649
|
|
|
$
|
3,466
|
|
Non-current tax liabilities (1)
|
138,305
|
|
|
136,323
|
|
||
Other liabilities
|
37,268
|
|
|
37,673
|
|
||
Total
|
$
|
179,222
|
|
|
$
|
177,462
|
|
(1)
|
Other long-term investments as of December 27, 2019 include investments that are not carried at fair value including an equity method investment of $1.5 million.
|
(1)
|
Other long-term investments as of September 27, 2019 include an investment that is not carried at fair value including an equity method investment of $1.7 million.
|
|
December 27, 2019
|
|
September 27, 2019
|
||||||||||||||||||||||
|
Less Than 12 Months
|
12 Months Or Greater
|
|
Less Than 12 Months
|
12 Months Or Greater
|
||||||||||||||||||||
Investment Type
|
Fair Value
|
Gross Unrealized Losses
|
Fair Value
|
Gross Unrealized Losses
|
|
Fair Value
|
Gross Unrealized Losses
|
Fair Value
|
Gross Unrealized Losses
|
||||||||||||||||
Certificate of deposit
|
$
|
4,298
|
|
$
|
(2
|
)
|
$
|
—
|
|
$
|
—
|
|
|
$
|
300
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
U.S. agency securities
|
333
|
|
—
|
|
4,797
|
|
(1
|
)
|
|
—
|
|
—
|
|
4,787
|
|
(9
|
)
|
||||||||
Government bonds
|
38,385
|
|
(21
|
)
|
—
|
|
—
|
|
|
1,426
|
|
—
|
|
—
|
|
—
|
|
||||||||
Commercial paper
|
11,787
|
|
(9
|
)
|
—
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
||||||||
Corporate bonds
|
36,756
|
|
(100
|
)
|
11,374
|
|
(10
|
)
|
|
7,647
|
|
(3
|
)
|
27,078
|
|
(32
|
)
|
||||||||
Municipal debt securities
|
3,968
|
|
(2
|
)
|
—
|
|
—
|
|
|
9,552
|
|
(13
|
)
|
900
|
|
—
|
|
||||||||
Total
|
$
|
95,527
|
|
$
|
(134
|
)
|
$
|
16,171
|
|
$
|
(11
|
)
|
|
$
|
18,925
|
|
$
|
(16
|
)
|
$
|
32,765
|
|
$
|
(41
|
)
|
|
December 27, 2019
|
|
September 27, 2019
|
||||||||||
Range of maturity
|
Amortized Cost
|
Fair Value
|
|
Amortized Cost
|
Fair Value
|
||||||||
Due within 1 year
|
$
|
192,373
|
|
$
|
192,537
|
|
|
$
|
238,186
|
|
$
|
238,354
|
|
Due in 1 to 2 years
|
57,931
|
|
58,481
|
|
|
93,948
|
|
94,899
|
|
||||
Due in 2 to 3 years
|
81,337
|
|
81,744
|
|
|
81,793
|
|
82,957
|
|
||||
Total
|
$
|
331,641
|
|
$
|
332,762
|
|
|
$
|
413,927
|
|
$
|
416,210
|
|
|
December 27,
2019 |
|
September 27,
2019 |
||||
Land
|
$
|
41,980
|
|
|
$
|
41,918
|
|
Buildings and building improvements
|
283,462
|
|
|
282,924
|
|
||
Leasehold improvements
|
67,253
|
|
|
66,730
|
|
||
Machinery and equipment
|
127,183
|
|
|
128,525
|
|
||
Computer equipment and software
|
219,773
|
|
|
219,455
|
|
||
Furniture and fixtures
|
31,571
|
|
|
34,191
|
|
||
Equipment provided under operating leases
|
174,155
|
|
|
161,372
|
|
||
Construction-in-progress
|
32,251
|
|
|
19,616
|
|
||
Property, plant, and equipment, gross
|
977,628
|
|
|
954,731
|
|
||
Less: accumulated depreciation
|
(428,133
|
)
|
|
(417,299
|
)
|
||
Property, plant, & equipment, net
|
$
|
549,495
|
|
|
$
|
537,432
|
|
|
Fiscal Quarter Ended
|
|
|
December 27, 2019
|
|
Lease cost
|
|
|
Operating lease cost
|
5,356
|
|
Variable lease cost
|
394
|
|
Total lease cost
|
5,750
|
|
|
Fiscal Quarter Ended
|
|
|
December 27, 2019
|
|
Other information
|
|
|
Cash paid for amounts included in the measurement of lease liabilities:
|
|
|
Operating cash flows from operating leases
|
5,241
|
|
Right-of-use assets obtained in exchange for lease obligations:
|
|
|
Operating lease liabilities
|
12,816
|
|
|
December 27, 2019
|
|
Weighted-average remaining lease term
|
|
|
Operating leases
|
7.3 years
|
|
Weighted-average discount rate
|
|
|
Operating leases
|
3.4
|
%
|
|
December 27, 2019
|
|
September 27, 2019
|
||
|
Operating Leases
|
|
Operating Leases
|
||
Remainder of Fiscal 2020
|
15,386
|
|
|
17,231
|
|
Fiscal 2021
|
13,643
|
|
|
9,329
|
|
Fiscal 2022
|
11,336
|
|
|
7,191
|
|
Fiscal 2023
|
9,375
|
|
|
6,218
|
|
Fiscal 2024
|
6,703
|
|
|
4,499
|
|
Thereafter
|
29,320
|
|
|
12,355
|
|
Total undiscounted lease payments
|
85,763
|
|
|
56,823
|
|
Less: imputed interest
|
(12,174
|
)
|
|
|
|
Total lease liabilities
|
73,589
|
|
|
|
|
December 27, 2019
|
||||
|
Operating Leases
|
|
Sales-Type Leases
|
||
Remainder of Fiscal 2020
|
1,669
|
|
|
4,059
|
|
Fiscal 2021
|
2,227
|
|
|
1,595
|
|
Fiscal 2022
|
2,227
|
|
|
1,595
|
|
Fiscal 2023
|
2,153
|
|
|
1,595
|
|
Fiscal 2024
|
1,107
|
|
|
795
|
|
Thereafter
|
—
|
|
|
790
|
|
Total undiscounted cash flows
|
9,383
|
|
|
10,429
|
|
Less: present value of lease payments (recognized as lease receivables)
|
|
|
(8,095
|
)
|
|
Difference
|
|
|
2,334
|
|
|
Goodwill
|
||
Balance at September 27, 2019
|
$
|
334,829
|
|
Acquired goodwill
|
—
|
|
|
Translation adjustments
|
614
|
|
|
Balance at December 27, 2019
|
$
|
335,443
|
|
|
December 27, 2019
|
|
September 27, 2019
|
||||||||||||||||
Intangible Assets
|
Cost
|
Accumulated
Amortization
|
Net
|
|
Cost
|
Accumulated
Amortization
|
Net
|
||||||||||||
Acquired patents and technology
|
$
|
340,519
|
|
$
|
(183,283
|
)
|
$
|
157,236
|
|
|
$
|
338,075
|
|
$
|
(176,867
|
)
|
$
|
161,208
|
|
Customer relationships
|
64,718
|
|
(46,417
|
)
|
18,301
|
|
|
64,728
|
|
(45,510
|
)
|
19,218
|
|
||||||
Other intangibles
|
22,942
|
|
(22,498
|
)
|
444
|
|
|
22,902
|
|
(22,437
|
)
|
465
|
|
||||||
Total
|
$
|
428,179
|
|
$
|
(252,198
|
)
|
$
|
175,981
|
|
|
$
|
425,705
|
|
$
|
(244,814
|
)
|
$
|
180,891
|
|
Fiscal Period
|
Total Purchase Consideration (1)
|
Weighted-Average
Useful Life
|
|
(in millions)
|
(in years)
|
Fiscal 2019
|
|
|
Q1 - Quarter ended December 28, 2018
|
$12.1
|
11.6
|
Fiscal 2020
|
|
|
Q1 - Quarter ended December 27, 2019
|
$2.9
|
14.0
|
Fiscal Year
|
Amortization Expense
|
||
|
(in thousands)
|
||
Remainder of 2020
|
$
|
22,346
|
|
2021
|
29,585
|
|
|
2022
|
27,580
|
|
|
2023
|
23,898
|
|
|
2024
|
22,273
|
|
|
Thereafter
|
50,299
|
|
|
Total
|
$
|
175,981
|
|
|
Shares
|
Weighted-Average
Exercise Price
|
Weighted-Average
Remaining
Contractual Life
|
Aggregate
Intrinsic
Value (1)
|
|||||
|
(in thousands)
|
|
(in years)
|
(in thousands)
|
|||||
Options outstanding at September 27, 2019
|
7,201
|
|
$
|
48.03
|
|
|
|
||
Grants
|
1,058
|
|
68.41
|
|
|
|
|||
Exercises
|
(441
|
)
|
38.92
|
|
|
|
|||
Forfeitures and cancellations
|
(23
|
)
|
60.18
|
|
|
|
|||
Options outstanding at December 27, 2019
|
7,795
|
|
51.28
|
|
6.60
|
$
|
132,844
|
|
|
Options vested and expected to vest at December 27, 2019
|
7,369
|
|
50.45
|
|
6.48
|
131,897
|
|
||
Options exercisable at December 27, 2019
|
4,633
|
|
$
|
43.13
|
|
5.43
|
116,784
|
|
(1)
|
Aggregate intrinsic value is based on the closing price of our Class A common stock on December 27, 2019 of $68.34 and excludes the impact of options that were not in-the-money.
|
|
Shares
|
Weighted-Average
Grant Date
Fair Value
|
|||
|
(in thousands)
|
|
|||
Non-vested at September 27, 2019
|
2,805
|
|
$
|
58.84
|
|
Granted
|
1,214
|
|
66.28
|
|
|
Vested
|
(897
|
)
|
51.77
|
|
|
Forfeitures
|
(43
|
)
|
59.23
|
|
|
Non-vested at December 27, 2019
|
3,079
|
|
$
|
62.39
|
|
|
Fiscal Quarter Ended
|
|||
|
December 27,
2019 |
December 28,
2018 |
||
Expected life (in years)
|
4.91
|
|
4.90
|
|
Risk-free interest rate
|
1.7
|
%
|
2.7
|
%
|
Expected stock price volatility
|
23.9
|
%
|
22.9
|
%
|
Dividend yield
|
1.3
|
%
|
1.1
|
%
|
|
Fiscal Quarter Ended
|
|||||
|
December 27,
2019 |
December 28,
2018 |
||||
Compensation expense - by type
|
|
|
||||
Stock options
|
$
|
4,546
|
|
$
|
5,022
|
|
Restricted stock units
|
16,967
|
|
15,375
|
|
||
Employee stock purchase plan
|
1,101
|
|
1,085
|
|
||
Total stock-based compensation
|
22,614
|
|
21,482
|
|
||
Benefit from income taxes
|
(3,594
|
)
|
(3,760
|
)
|
||
Total stock-based compensation, net of tax
|
$
|
19,020
|
|
$
|
17,722
|
|
|
Fiscal Quarter Ended
|
|||||
|
December 27,
2019 |
December 28,
2018 |
||||
Compensation expense - by classification
|
|
|
||||
Cost of products and services
|
$
|
543
|
|
$
|
488
|
|
Research and development
|
6,987
|
|
6,241
|
|
||
Sales and marketing
|
8,174
|
|
8,217
|
|
||
General and administrative
|
6,910
|
|
6,536
|
|
||
Total stock-based compensation expense
|
22,614
|
|
21,482
|
|
||
Benefit from income taxes
|
(3,594
|
)
|
(3,760
|
)
|
||
Total stock-based compensation, net of tax
|
$
|
19,020
|
|
$
|
17,722
|
|
|
Fiscal Quarter Ended
|
|||||
|
December 27,
2019 |
December 28,
2018 |
||||
Tax benefit - shares issued under ESPP
|
$
|
202
|
|
$
|
142
|
|
Authorization Period
|
Authorization Amount
|
||
Fiscal 2010: November 2009
|
$
|
250,000
|
|
Fiscal 2010: July 2010
|
300,000
|
|
|
Fiscal 2011: July 2011
|
250,000
|
|
|
Fiscal 2012: February 2012
|
100,000
|
|
|
Fiscal 2015: October 2014
|
200,000
|
|
|
Fiscal 2017: January 2017
|
200,000
|
|
|
Fiscal 2018: July 2018
|
350,000
|
|
|
Fiscal 2019: July 2019
|
350,000
|
|
|
Total
|
$
|
2,000,000
|
|
Quarterly Repurchase Activity
|
Shares
Repurchased
|
Cost in thousands (1)
|
Average Price Paid Per Share (2)
|
|||||
|
|
|
|
|||||
Q1 - Quarter ended December 27, 2019
|
432,042
|
|
$
|
30,003
|
|
$
|
69.44
|
|
Total
|
432,042
|
|
$
|
30,003
|
|
|
(1)
|
Cost of share repurchases includes the price paid per share and applicable commissions.
|
(2)
|
Average price paid per share excludes commission costs.
|
Fiscal Period
|
Announcement Date
|
Record Date
|
Payment Date
|
Cash Dividend Per Common Share
|
Dividend Payment
|
|
||
Fiscal 2020
|
|
|
|
|
|
|
||
Q1 - Quarter ended December 27, 2019
|
January 29, 2020
|
February 10, 2020
|
February 20, 2020
|
$
|
0.22
|
|
$22.2 million
|
(1)
|
(1)
|
The amount of the dividend payment is estimated based on the number of shares of our Class A and Class B common stock that we estimate will be outstanding as of the Record Date.
|
|
Fiscal Quarter Ended
December 27, 2019 |
|||||||||||
|
Investment Securities
|
Cash Flow Hedges
|
Currency Translation Adjustments
|
Total
|
||||||||
Beginning Balance
|
$
|
2,198
|
|
$
|
—
|
|
$
|
(22,823
|
)
|
$
|
(20,625
|
)
|
Other comprehensive income before reclassifications:
|
|
|
|
|
|
|
|
|
||||
Unrealized gains/(losses)
|
(2,209
|
)
|
315
|
|
—
|
|
(1,894
|
)
|
||||
Foreign currency translation gains/(losses) (1)
|
—
|
|
—
|
|
3,403
|
|
3,403
|
|
||||
Income tax effect - benefit/(expense)
|
—
|
|
(37
|
)
|
40
|
|
3
|
|
||||
Net of tax
|
(2,209
|
)
|
278
|
|
3,443
|
|
1,512
|
|
||||
Amounts reclassified from AOCI into earnings:
|
|
|
|
|
|
|
|
|||||
Realized gains/(losses) (1)
|
1,308
|
|
6
|
|
—
|
|
1,314
|
|
||||
Income tax effect - benefit/(expense) (2)
|
(261
|
)
|
—
|
|
—
|
|
(261
|
)
|
||||
Net of tax
|
1,047
|
|
6
|
|
—
|
|
1,053
|
|
||||
Net current-period other comprehensive income/(loss)
|
(1,162
|
)
|
284
|
|
3,443
|
|
2,565
|
|
||||
Ending Balance
|
$
|
1,036
|
|
$
|
284
|
|
$
|
(19,380
|
)
|
$
|
(18,060
|
)
|
|
Fiscal Quarter Ended
December 28, 2018 |
|||||||||||
|
Investment Securities
|
Cash Flow Hedges
|
Currency Translation Adjustments
|
Total
|
||||||||
Beginning Balance
|
$
|
(2,948
|
)
|
$
|
—
|
|
$
|
(12,884
|
)
|
$
|
(15,832
|
)
|
Other comprehensive income before reclassifications:
|
|
|
|
|
|
|
|
|||||
Unrealized gains/(losses)
|
931
|
|
—
|
|
—
|
|
931
|
|
||||
Foreign currency translation gains/(losses) (1)
|
—
|
|
—
|
|
(3,577
|
)
|
(3,577
|
)
|
||||
Income tax effect - benefit/(expense)
|
—
|
|
—
|
|
—
|
|
—
|
|
||||
Net of tax
|
931
|
|
—
|
|
(3,577
|
)
|
(2,646
|
)
|
||||
Amounts reclassified from AOCI into earnings:
|
|
|
|
|
|
|||||||
Realized gains/(losses) (1)
|
(201
|
)
|
—
|
|
—
|
|
(201
|
)
|
||||
Income tax effect - benefit/(expense) (2)
|
40
|
|
—
|
|
—
|
|
40
|
|
||||
Net of tax
|
(161
|
)
|
—
|
|
—
|
|
(161
|
)
|
||||
Net current-period other comprehensive income/(loss)
|
770
|
|
—
|
|
(3,577
|
)
|
(2,807
|
)
|
||||
Ending Balance
|
$
|
(2,178
|
)
|
$
|
—
|
|
$
|
(16,461
|
)
|
$
|
(18,639
|
)
|
(1)
|
Realized gains or losses, if any, from the sale of our AFS investment securities or from foreign currency translation adjustments are included within other income/expense, net in our consolidated statements of operations. Realized gains or losses on cash flow hedges are included in operating expenses together with the hedged item.
|
(2)
|
The income tax benefit or expense is included within provision for income taxes in our consolidated statements of operations.
|
|
Fiscal Quarter Ended
|
|||||
|
December 27,
2019 |
December 28,
2018 |
||||
Numerator:
|
|
|
||||
Net income attributable to Dolby Laboratories, Inc.
|
$
|
48,753
|
|
$
|
98,219
|
|
|
|
|
||||
Denominator:
|
|
|
||||
Weighted-average shares outstanding—basic
|
100,336
|
|
102,677
|
|
||
Potential common shares from options to purchase common stock
|
1,711
|
|
2,251
|
|
||
Potential common shares from restricted stock units
|
1,020
|
|
1,202
|
|
||
Potential common shares from ESPP
|
11
|
|
—
|
|
||
Weighted-average shares outstanding—diluted
|
103,078
|
|
106,130
|
|
||
|
|
|
||||
Net income per share attributable to Dolby Laboratories, Inc.:
|
|
|
||||
Basic
|
$
|
0.49
|
|
$
|
0.96
|
|
Diluted
|
$
|
0.47
|
|
$
|
0.93
|
|
|
|
|
||||
Antidilutive awards excluded from calculation:
|
|
|
||||
Stock options
|
2,623
|
|
1,583
|
|
||
Restricted stock units
|
8
|
|
10
|
|
||
ESPP
|
3
|
|
—
|
|
|
Severance
|
Leased facility exit costs
|
Fixed assets write-off
|
Other associated costs
|
Total
|
||||||||||
Balance at September 28, 2018
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
124
|
|
$
|
124
|
|
Restructuring charges/(credits)
|
3,134
|
|
18,261
|
|
15,216
|
|
(53
|
)
|
36,558
|
|
|||||
Cash payments
|
(3,006
|
)
|
(4,577
|
)
|
—
|
|
(130
|
)
|
(7,713
|
)
|
|||||
Non-cash and other adjustments
|
—
|
|
2,039
|
|
(15,216
|
)
|
59
|
|
(13,118
|
)
|
|||||
Balance at September 27, 2019
|
$
|
128
|
|
$
|
15,723
|
|
$
|
—
|
|
$
|
—
|
|
$
|
15,851
|
|
Restructuring charges
|
—
|
|
675
|
|
—
|
|
—
|
|
675
|
|
|||||
Cash payments
|
(72
|
)
|
(8,502
|
)
|
—
|
|
—
|
|
(8,574
|
)
|
|||||
Non-cash and other adjustments
|
158
|
|
24
|
|
—
|
|
—
|
|
182
|
|
|||||
Balance at December 27, 2019
|
$
|
214
|
|
$
|
7,920
|
|
$
|
—
|
|
$
|
—
|
|
$
|
8,134
|
|
|
Payments Due By Fiscal Period
|
||||||||||||||||||||
|
Remainder of Fiscal 2020
|
Fiscal
2021 |
Fiscal
2022 |
Fiscal
2023 |
Fiscal
2024 |
Thereafter
|
Total
|
||||||||||||||
Naming rights
|
$
|
3,954
|
|
$
|
8,008
|
|
$
|
8,108
|
|
$
|
8,209
|
|
$
|
8,312
|
|
$
|
70,344
|
|
$
|
106,935
|
|
Purchase obligations
|
23,161
|
|
4,615
|
|
2,176
|
|
—
|
|
—
|
|
—
|
|
29,952
|
|
|||||||
Donation commitments
|
4,077
|
|
141
|
|
141
|
|
141
|
|
141
|
|
1,059
|
|
5,700
|
|
|||||||
Total
|
$
|
31,192
|
|
$
|
12,764
|
|
$
|
10,425
|
|
$
|
8,350
|
|
$
|
8,453
|
|
$
|
71,403
|
|
$
|
142,587
|
|
Technology
|
Description
|
AAC & HE-AAC
|
An advanced digital audio codec solution with higher bandwidth efficiency used for a wide range of media applications.
|
AVC
|
A digital video codec with high bandwidth efficiency used in a wide range of media devices.
|
Dolby® AC-4
|
A next-generation digital audio coding technology that increases transmission efficiency while delivering new audio experiences, including Dolby Atmos, to a wide range of playback devices.
|
Dolby Atmos®
|
An object-oriented audio technology for cinema and a wide range of media devices that allows sound to be precisely placed and moved anywhere in the listening environment including the overhead dimension. Dolby Atmos is an immersive experience that can be provided via multiple Dolby audio coding technologies.
|
Dolby Digital®
|
A digital audio coding technology that provides multichannel sound to a variety of media applications.
|
Dolby Digital Plus™
|
An advanced digital audio coding technology that offers more efficient audio transmission for a wide range of media applications and devices.
|
Dolby® TrueHD
|
A digital audio coding technology providing lossless encoding for premium quality media applications.
|
Dolby Vision®
|
An imaging technology combining high dynamic range and dynamic metadata to deliver higher color contrast, brighter contrast, and improved details for cinema and a wide range of media devices.
|
Dolby Voice®
|
An audio conferencing technology with superior spatial perception, voice clarity, and background noise reduction that emulates the in-person meeting experience.
|
HEVC
|
A next-generation digital video codec with high bandwidth efficiency to support ultra-high definition experiences for a wide range of media devices.
|
Product
|
Description
|
|
Cinema
|
Cinema Imaging Products
|
Digital Cinema Servers used to load, store, decrypt, decode, watermark, and playback digital film files for presentation on digital cinema projectors and software used to encrypt, encode, and package digital media files for distribution.
|
Cinema Audio Products
|
Cinema Processors, amplifiers, and loudspeakers used to decode, render, and optimally playback digital cinema soundtracks including those using Dolby Atmos.
|
|
Other
|
Dolby Conference Phone
|
An integral hardware component of the Dolby Voice conferencing solution that enhances full-room voice capture, spatial voice separation, and playback.
|
Dolby Voice Room
|
Video conferencing solution for huddle rooms and small conference rooms that combines a camera product with the Dolby Conference Phone and Dolby Voice technology.
|
|
Other Products
|
3-D glasses and kits, broadcast hardware and software used to encode, transmit, and decode multiple channels of high quality audio for DTV and HDTV distribution, monitors, and accessibility solutions for hearing and visually impaired consumers.
|
|
Fiscal Quarter Ended
|
Change
|
||
Licensing
|
December 27,
2019 |
December 28,
2018 |
$
|
%
|
Revenue
|
$257,683
|
$260,279
|
$(2,596)
|
(1)%
|
Percentage of total revenue
|
88%
|
86%
|
|
|
Cost of licensing
|
12,342
|
11,397
|
945
|
8%
|
Gross margin
|
245,341
|
248,882
|
(3,541)
|
(1)%
|
Gross margin percentage
|
95%
|
96%
|
|
|
Factor
|
Revenue
|
Gross Margin
|
||
PC
|
á
|
Higher revenues from recoveries and higher adoption of our newer technologies in more PC models
|
ßà
|
No significant fluctuations
|
Other
|
â
|
Lower revenues from automotive recoveries and gaming
|
||
CE
|
á
|
Higher adoption of our technologies, driven by higher volume of DMAs
|
||
Broadcast
|
á
|
Higher recoveries and higher revenues from increased adoption
|
||
Mobile
|
ßà
|
Higher adoption of our technologies, offset by lower recoveries
|
|
Fiscal Quarter Ended
|
Change
|
||
Products and Services
|
December 27,
2019 |
December 28,
2018 |
$
|
%
|
Revenue
|
$34,194
|
$42,097
|
$(7,903)
|
(19)%
|
Percentage of total revenue
|
12%
|
14%
|
|
|
Cost of products and services
|
24,973
|
27,232
|
(2,259)
|
(8)%
|
Gross margin
|
9,221
|
14,865
|
(5,644)
|
(38)%
|
Gross margin percentage
|
27%
|
35%
|
|
|
Factor
|
Revenue
|
Gross Margin
|
||
Products
|
â
|
Prior period included revenue from Dolby Cinema sales-type leases (hybrid agreements), partially offset by higher units of Dolby Voice products and cinema equipment
|
â
|
Lower margins due to less revenue from Dolby Cinema hybrid agreements which are typically higher in gross margin relative to other product sales
|
Services
|
ßà
|
No significant fluctuations
|
á
|
Higher utilization of available capacity
|
|
Fiscal Quarter Ended
|
Change
|
||
|
December 27,
2019 |
December 28,
2018 |
$
|
%
|
Research and development
|
$57,650
|
$58,647
|
$(997)
|
(2)%
|
Percentage of total revenue
|
20%
|
19%
|
|
|
Category
|
Key Drivers
|
|
Research & Development
|
ßà
|
No significant fluctuations
|
|
Fiscal Quarter Ended
|
Change
|
||
|
December 27,
2019 |
December 28,
2018 |
$
|
%
|
Sales and marketing
|
$95,118
|
$85,602
|
$9,516
|
11%
|
Percentage of total revenue
|
33%
|
28%
|
|
|
Category
|
Key Drivers
|
|
Marketing Programs
|
á
|
Higher costs related to marketing efforts for growth initiatives and company branding activities
|
Legal, Professional, & Consulting
|
á
|
Increased IP related activities aimed at revenue generation
|
|
Fiscal Quarter Ended
|
Change
|
||
|
December 27,
2019 |
December 28,
2018 |
$
|
%
|
General and administrative
|
$52,529
|
$50,813
|
$1,716
|
3%
|
Percentage of total revenue
|
18%
|
17%
|
|
|
Category
|
Key Drivers
|
|
Compensation & Benefits
|
á
|
Higher headcount and merit increases across the existing employee base
|
|
Fiscal Quarter Ended
|
Change
|
||
|
December 27,
2019 |
December 28,
2018 |
$
|
%
|
Other income/(expense)
|
$5,864
|
$5,583
|
$281
|
5%
|
Percentage of total revenue
|
2%
|
2%
|
|
|
Category
|
Key Drivers
|
|
Other Income/Expense
|
ßà
|
No significant fluctuations
|
|
Fiscal Quarter Ended
|
|
|
December 27,
2019 |
December 28,
2018 |
(Provision for)/benefit from income taxes
|
$(5,863)
|
$24,104
|
Effective tax rate
|
10.8%
|
(32.5)%
|
|
December 27,
2019 |
September 27,
2019 |
||||
Cash and cash equivalents
|
$
|
741,429
|
|
$
|
797,210
|
|
Short-term investments
|
170,234
|
|
119,146
|
|
||
Long-term investments
|
141,720
|
|
179,587
|
|
||
Accounts receivable, net
|
191,001
|
|
189,115
|
|
||
Accounts payable and accrued liabilities
|
255,752
|
|
283,356
|
|
||
Working capital
|
1,107,549
|
|
1,074,687
|
|
|
Fiscal Quarter Ended
|
|||||
|
December 27,
2019 |
December 28,
2018 |
||||
Net cash provided by operating activities
|
$
|
31,159
|
|
$
|
56,952
|
|
Factor
|
Impact On Cash Flows
|
|
Net Income
|
â
|
Lower revenues and increased expenses compared to the prior year
|
Deferred Income Taxes
|
á
|
Prior period deferred tax asset activity included an additional tax benefit related to adjustments to the Tax Reform Transition Tax
|
|
Fiscal Quarter Ended
|
|||||
|
December 27,
2019 |
December 28,
2018 |
||||
Net cash used in investing activities
|
$
|
(37,407
|
)
|
$
|
(41,566
|
)
|
Factor
|
Impact On Cash Flows
|
|
Intangible Asset Acquisitions
|
â
|
Lower outflows for purchases of intangible assets
|
|
Fiscal Quarter Ended
|
|||||
|
December 27,
2019 |
December 28,
2018 |
||||
Net cash used in financing activities
|
$
|
(48,276
|
)
|
$
|
(138,431
|
)
|
Factor
|
Impact On Cash Flows
|
|
Share Repurchases
|
á
|
Lower outflows from common stock repurchases
|
Common Stock Issuance
|
á
|
Higher inflows from employee stock option exercises
|
•
|
Australian Dollar
|
•
|
British Pound
|
•
|
Chinese Yuan
|
•
|
Euro
|
•
|
Polish Zloty
|
•
|
Royalty reports including positive or negative corrective adjustments;
|
•
|
Retroactive royalties that cover extended periods of time; and
|
•
|
Timing of revenue recognition under licensing agreements and other contractual arrangements, including recognition of unusually large amounts of revenue in any given quarter.
|
•
|
Rapid technological change;
|
•
|
New and improved technology and frequent product introductions;
|
•
|
Changing consumer and licensee demands;
|
•
|
Evolving industry standards; and
|
•
|
Technology and product obsolescence.
|
•
|
Possibility that innovations may not be protectable;
|
•
|
Failure to protect innovations that later turn out to be important;
|
•
|
Insufficient patent protection to prevent third parties from designing around our patent claims;
|
•
|
Our pending patent applications may not be approved; and
|
•
|
Possibility that an issued patent may later be found to be invalid or unenforceable.
|
•
|
Our ability to enforce our contractual and IP rights, especially in countries that do not recognize and enforce IP rights to the same extent as the U.S., Japan, Korea, and European countries do, which increases the risk of unauthorized use of our technologies;
|
•
|
Limited or no patent protection for our DD technologies in countries such as China, Taiwan, and India, which may require us to obtain patent rights for new and existing technologies in order to grow or maintain our revenue; and
|
•
|
Because of limitations in the legal systems in many countries, our ability to obtain and enforce patents in many countries is uncertain, and we must strengthen and develop relationships with entertainment industry participants worldwide to increase our ability to enforce our IP and contractual rights without relying solely on the legal systems in the countries in which we operate.
|
•
|
Content creators, such as film directors, studios, mobile and online content producers, and music producers;
|
•
|
Content distributors, such as studios, film exhibitors, broadcasters, operators, and OTT video service providers and video game publishers;
|
•
|
Leading companies in the audio and video conferencing markets; and
|
•
|
Device manufacturers.
|
•
|
Diversion of management time and focus from operating our business to acquisition integration
|
•
|
Cultural and logistical challenges associated with integrating employees from acquired businesses into our organization;
|
•
|
Retaining employees, suppliers and customers from businesses we acquire;
|
•
|
The need to implement or improve internal controls, procedures, and policies appropriate for a public company at businesses that prior to the acquisition may have lacked effective controls, procedures, and policies;
|
•
|
Possible write-offs or impairment charges resulting from acquisitions;
|
•
|
Unanticipated or unknown liabilities relating to acquired businesses; and
|
•
|
The need to integrate acquired businesses’ accounting, management information, manufacturing, human resources, and other administrative systems to permit effective management.
|
•
|
U.S. and foreign government trade restrictions, including those which may impose restrictions on the importation of programming, technology, or components to or from the U.S., and those which may put restrictions or prohibitions on the exportation, reexportation, sale, shipment or other transfer of programming, technology, components, and/or services to foreign persons;
|
•
|
Changes in trade relationships, including new tariffs, trade protection measures, import or export licensing requirements, trade embargoes and other trade barriers;
|
•
|
Tariffs imposed by the U.S. on goods from other countries or tariffs imposed by other countries on U.S. goods, including the tariffs imposed over the course of 2018 and 2019 by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods, the scope and duration of which remain uncertain;
|
•
|
Compliance with applicable international laws and regulations, including antitrust and other competition laws, that may change unexpectedly, differ, or conflict with laws in other countries where we conduct business, or are otherwise not harmonized with one another;
|
•
|
Foreign government taxes, regulations, and permit requirements, including foreign taxes that we may not be able to offset against taxes imposed upon us in the U.S., and other laws limiting our ability to repatriate funds to the U.S.;
|
•
|
Potential adverse changes in the political and/or economic stability of foreign countries or in their diplomatic relations with the U.S.;
|
•
|
Difficulty in establishing, staffing, and managing foreign operations, including but not limited to restrictions on the ability to obtain or retain licenses required for operation, relationships with local labor unions and works councils, investment restrictions and/or requirements, and restrictions on foreign ownership of subsidiaries;
|
•
|
Adverse fluctuations in foreign currency exchange rates and interest rates, including risks related to any interest rate swap or other hedging activities we undertake;
|
•
|
Poor recognition of IP rights;
|
•
|
Difficulties in enforcing contractual rights;
|
•
|
Multi-jurisdictional data protection and privacy laws, including the European Union's General Data Protection Regulation and restrictions on transferring personally identifiable information outside of a jurisdiction;
|
•
|
Political or social instability in the U.K. and Europe (including but not limited to uncertainty resulting from the Brexit referendum in the U.K.) and in Russia, the Middle East, North Africa, Latin America and other emerging markets;
|
•
|
Uncertainties related to any geopolitical, economic and regulatory effects or changes due to the current political climate in the U.S.;
|
•
|
Natural disasters, war or events of terrorism; and
|
•
|
The global macroeconomic environment and potential slowing of key markets we serve, such as the current economic challenges in China.
|
•
|
Changes in geographic mix of earnings, where earnings are lower than anticipated in countries with lower tax rates and higher than anticipated in countries with higher tax rates;
|
•
|
Changes in the valuation of our deferred tax assets and liabilities;
|
•
|
Changes in transfer pricing arrangements;
|
•
|
Outcomes of tax audits;
|
•
|
Changes in accounting principles; or
|
•
|
Changes in tax laws and regulations in the countries in which we operate, including an increase in tax rates, or an adverse change in the treatment of an item of income or expense.
|
Repurchase Activity
|
Total Shares Repurchased
|
Average Price
Paid Per Share (1) |
Total Shares Purchased As Part Of Publicly Announced Programs
|
Remaining Authorized Share Repurchases (2)
|
September 28, 2019 - October 25, 2019
|
—
|
—
|
—
|
$360.9 million
|
October 26, 2019 - November 22, 2019
|
289,875
|
69.51
|
289,875
|
$340.8 million
|
November 23, 2019 - December 27, 2019
|
142,167
|
69.29
|
142,167
|
$330.9 million
|
Total
|
432,042
|
|
432,042
|
|
(1)
|
Average price paid per share excludes commission costs.
|
(2)
|
Amounts represent the approximate dollar value of the maximum remaining number of shares that may yet be purchased under the stock repurchase program, and excludes commission costs.
|
Exhibit
Number
|
|
Description
|
|
Incorporated By Reference Herein
|
|
|
||||
|
Form
|
|
File Number
|
|
Date
|
|
Provided Herewith
|
|||
10.1
|
|
|
|
|
|
|
|
|
X
|
|
31.1
|
|
|
|
|
|
|
|
|
X
|
|
31.2
|
|
|
|
|
|
|
|
|
X
|
|
32.1+
|
|
|
|
|
|
|
|
|
X
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
X
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
X
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
X
|
101.DEF
|
|
XBRL Extension Definition
|
|
|
|
|
|
|
|
X
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
X
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
X
|
104
|
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
|
|
|
|
|
|
|
|
X
|
DOLBY LABORATORIES, INC.
|
|
By:
|
/S/ LEWIS CHEW
|
|
Lewis Chew
|
|
Executive Vice President and Chief Financial Officer
|
|
(Principal Financial Officer)
|
Date of Grant:
|
[ ]
|
|
|
Performance Period:
|
[ ]
|
|
|
Threshold Number of Restricted Stock Units (“Threshold”):
(Target number x [#]%)
|
[ ]
|
|
|
Target Number of Restricted Stock Units (“Target”):
|
[ ]
|
|
|
Maximum Number of Restricted Stock Units (“Maximum”):
(Target number x [#]%)
|
[ ]
|
|
|
1.
|
Notwithstanding anything to the contrary in this Agreement, the Performance Period shall be deemed to end on the closing date of such merger or Change in Control and the per share value of the consideration of the Company’s Class A Common Stock in such transaction shall be used to calculate Annualized TSR instead and in lieu of the Ending Stock Price (it being understood, for the avoidance of doubt, that such calculation will be adjusted to reflect the reinvestment of dividends paid during the Performance Period). The Administrator may determine Annualized TSR pursuant to this clause 1, in its sole discretion, within the ten (10) day period prior to the closing date of such merger or Change in Control;
|
2.
|
In the event the successor corporation assumes, substitutes or replaces the Award:
|
a.
|
Vested Eligible RSUs (as defined below) will vest on the date of the closing of the merger or Change in Control. “Vested Eligible RSUs” will equal (x) the number of Eligible RSUs subject to the Award, after giving effect to the Administrator’s determination of Annualized TSR in clause 1, above, multiplied by (y) a fraction, the numerator of which equals the numbers of days from the Date of Grant to the closing date of such merger or Change in Control and the denominator of which equals the number of days in the Performance Period had such merger or Change in Control not occurred (the “Proration Ratio”).
|
b.
|
Time-Based Eligible RSUs (as defined below) shall vest in equal monthly installments following the closing of the merger or Change in Control through the remainder of the Performance Period based solely on your continuing status as a Service Provider, subject to the terms of any acceleration provision provided for in any applicable written agreement between you and the Company (a “Company Agreement”) or any applicable Plan provision. Additionally, unless superseded by an acceleration provision in any Company Agreement, upon your termination by the Company or a Related Entity without Cause or your resignation for Good Reason, in either event, within the twelve (12) month period following the closing date of a merger or Change in Control, a number of your then outstanding Time-Based Eligible RSUs will vest equal to the product of (i) the number of Time-Based Eligible RSUs that would have vested had you remained a Service Provider for one year following your termination date, multiplied by (ii) the number of full years of service you have performed for the Company or a Related Entity as of the date of your termination, provided that in no event will more than 100% of the Time-Based Eligible RSUs subject to the Award vest pursuant to this provision. “Time-Based Eligible RSUs” will equal the portion of the Eligible RSUs subject to the Award, after giving effect to the Administrator’s
|
c.
|
Restricted Stock Units subject to the Award that do not become Eligible RSUs, after giving effect to the Administrator’s determination of Annualized TSR in clause 1, above, will, as of the closing date of the merger or Change in Control, be cancelled, forfeited and of no further effect.
|
3.
|
In the event the successor corporation does not assume, substitute or replace the Award, consistent with and subject to the terms of Section 17(c)(ii) of the Plan, you shall, immediately prior to the merger or Change in Control, fully vest in the Award as to all of the Eligible RSUs subject to the Award, after giving effect to the Administrator’s determination of Annualized TSR in clause 1, above.
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Dolby Laboratories, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
/s/ KEVIN J. YEAMAN
|
Kevin J. Yeaman
|
President and Chief Executive Officer
(Principal Executive Officer)
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Dolby Laboratories, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
/s/ LEWIS CHEW
|
Lewis Chew
|
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
|
•
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
•
|
The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ KEVIN J. YEAMAN
|
Kevin J. Yeaman
President and Chief Executive Officer
(Principal Executive Officer)
|
|
/s/ LEWIS CHEW
|
Lewis Chew
Executive Vice President and Chief Financial Officer (Principal Financial Officer)
|